Abstract
The technique of lymphatic mapping and sentinel lymph node (SLN) biopsy was introduced 20 years ago as an important advance in the management of patients with stage I and II melanoma. After 2 decades of experience, SLN biopsy and the practice of selective lymphadenectomy represents a minimally invasive standard of care that facilitates the accurate staging of the clinically negative regional lymph node basin, provides durable regional disease control, and improves survival in node-positive patients.
Original language | English (US) |
---|---|
Pages (from-to) | 57-78 |
Number of pages | 22 |
Journal | Surgical oncology clinics of North America |
Volume | 20 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2011 |
Keywords
- Biopsy
- Lymphadenectomy
- Lymphatic mapping
- Melanoma
- Sentinel lymph node
ASJC Scopus subject areas
- Surgery
- Oncology